SHENOUDA MAGED purchased 1.5% of their position (11.66K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $48.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/16/2025ACC: 0001213900-25-121973
+839.66K
Net shares
Net buyer
$48.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
839.66K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.66K
Price / share
$4.12
Trade value
$48.06K
% of position
1.5%
12/15/2025
788.34K→800K
Total
Net shares
+11.66K
Net value
$48.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | P · Purchase | +11.66K | $4.12 | $48.06K | 1.5% | 788.34K | 800K |
| Total | +11.66K | $48.06K | ||||||
Derivative Transactions1
Stock Appreciation Rights
Direct
Converts to
Common Stock
828K shares
Shares
+828K
Strike price
4.06
Held after
828K
Exercisable
—
12/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights Direct | Common Stock828K shares | 12/12/2025 | A · Award | +828K | 4.06 | — | 828K |